FIRST-IN-CLASS SMALL MOLECULE CANDIDATE NCGC72 (CD206 AGONIST) FOR IMMUNOLOGICALLY COLD SOLID ORGAN CANCERS

NIH RePORTER · NIH · N01 · $512,266 · view on reporter.nih.gov ↗

Abstract

The objectives of this study are to determine target organ toxicity and toxicokinetic (TK) parameters of NCGC72 and its reversibility.

Key facts

NIH application ID: 11219849
Project number: 75N95024D00020-0-759502400002-1
Recipient: IIT RESEARCH INSTITUTE
Principal Investigator: THOMAS HORN
Activity code: N01
Funding institute: NIH
Fiscal year: 2024
Award amount: $512,266
Award type: —
Project period: 2024-09-18 → 2025-02-10